Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

PURPOSE: To update eligibility and outcome measures in trials that evaluate systemic treatment for patients with progressive prostate cancer and castrate levels of testosterone. METHODS: A committee of investigators experienced in conducting trials for prostate cancer defined new consensus criteria...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Główni autorzy: Scher, Howard I., Halabi, Susan, Tannock, Ian, Morris, Michael, Sternberg, Cora N., Carducci, Michael A., Eisenberger, Mario A., Higano, Celestia, Bubley, Glenn J., Dreicer, Robert, Petrylak, Daniel, Kantoff, Philip, Basch, Ethan, Kelly, William Kevin, Figg, William D., Small, Eric J., Beer, Tomasz M., Wilding, George, Martin, Alison, Hussain, Maha
Format: Artigo
Język:Inglês
Wydane: 2008
Hasła przedmiotowe:
Article
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4010133/
https://ncbi.nlm.nih.gov/pubmed/18309951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.12.4487
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy